Expression of glypican-3, a new marker of hepatocellular carcinoma, in non-hepatic human malignant tumors

被引：0
|
作者：
Jia, Angela Y.
Hwang, Queena Y.
Allegretta, Mark
Guttmann, Ronald
Jothy, Serge
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] BioMosaics Inc, Burlington, VT USA
[3] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
来源：
MODERN PATHOLOGY | 2006年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
565
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [31] Evaluation of glypican-3 in patients with hepatocellular carcinoma
    Batbaatar, Batchimeg
    Gurbadam, Unenbat
    Tuvshinsaikhan, Odonchimeg
    Narmandakh, Nyam-Erdene
    Khatanbaatar, Gerelee
    Radnaabazar, Munkhbat
    Erdene-Ochir, Dulguun
    Boldbaatar, Minjuur
    Byambaragchaa, Munkhdelger
    Amankyeldi, Yerbolat
    Chogsom, Munkhzaya
    Ganbileg, Nyamsuren
    Batdelger, Amgalantuul
    Demchig, Tserendorj
    Nyam-Osor, Lkham
    Bayartugs, Batsaikhan
    Batmunkh, Enkhtsatsral
    Munkhjargal, Batkhishig
    Lonjid, Tulgaa
    Khasbagana, Batbayar
    Batmunkh, Munkhbat
    Jav, Sarantuya
    Semchin, Munkhbayar
    MOLECULAR AND CLINICAL ONCOLOGY, 2025, 22 (01)
  • [32] Glypican-3 as a specific biomarker for hepatocellular carcinoma
    Yao, Min
    Pan, Liu-Hong
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 122 - 123
  • [33] Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma
    Noriyuki Akutsu
    Hiroyuki Yamamoto
    Shigeru Sasaki
    Hiroaki Taniguchi
    Yoshiaki Arimura
    Kohzoh Imai
    Yasuhisa Shinomura
    World Journal of Gastroenterology, 2010, 16 (28) : 3521 - 3528
  • [34] Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma
    Akutsu, Noriyuki
    Yamamoto, Hiroyuki
    Sasaki, Shigeru
    Taniguchi, Hiroaki
    Arimura, Yoshiaki
    Imai, Kohzoh
    Shinomura, Yasuhisa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (28) : 3521 - 3528
  • [35] Imaging ligands targeting glypican-3 receptor expression in hepatocellular carcinoma
    Grega, Shaun D.
    Zheng, David X.
    Zheng, Qi-Huang
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 12 (04): : 113 - 121
  • [36] Glypican-3 Expression in Hepatocellular Carcinoma, Cirrhosis and Metastatic Adenocarcinomas of the Liver
    Tavares, Margaret
    Aguirre, Shanna
    Ota, Marlene
    Herrmann, Paul
    CANCER CYTOPATHOLOGY, 2009, 117 (05) : 411 - 411
  • [37] Glypican-3 as a specific biomarker for hepatocellular carcinoma
    Min Yao
    Liu-Hong Pan
    Deng-Fu Yao
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (02) : 122 - 123
  • [38] Glypican-3, over-expressed in hepatocellular carcinoma, is a useful tumor marker.
    Yeon, JE
    Kwon, JA
    Lee, KN
    Chang, YJ
    Lee, JY
    Seo, YS
    Kim, JY
    Park, JJ
    Kim, JS
    Bak, YT
    Byun, KS
    Lee, CH
    HEPATOLOGY, 2004, 40 (04) : 309A - 309A
  • [39] Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions
    Wang, H. L.
    Zhai, J.
    Adley, B.
    Anatelli, F.
    Chuang, S. T.
    King, X. J.
    MODERN PATHOLOGY, 2007, 20 : 295A - 295A
  • [40] Glypican-3 as a Useful Diagnostic Marker That Distinguishes Hepatocellular Carcinoma From Benign Hepatocellular Mass Lesions
    Wang, Hanlin L.
    Anatelli, Florencia
    Zhai, Qihui
    Adley, Brian
    Chuang, Shang-Tian
    Yang, Ximing J.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (11) : 1723 - 1728
12345